A Study of the Cutaneous Effects of Serotonin**From the Department of Dermatology, Walter Reed Army Institute of Research, Washington, D. C.  by Demis, D. Joseph et al.
A STUDY OF THE CUTANEOUS EFFECTS OF SEROTONJN*
CAPTAIN D. JOSEPH DEMIS, MC, USA, MAJOR MICHAEL J. DAVIS, MC, USA AND
CAPTAIN JAMES C. LAWLER, MC, USA
Patients with metastatic carcinoid tumors may
manifest a symptom complex referred to as the
malignant carcinoid syndrome. These patients
classically demonstrate cutaneous changes char-
acterized by transient flushing (predominantly
of the face) with areas of macular cyanosis within
the flush. The central areas of the flush tend to
fade, leaving erythema, blanching, and cyanosis.
This phenomenon has been termed a red, white
and blue response. Telangiectatic venules appear
as the flushing becomes chronic. Evidence of
edema formation has been noted only occasion-
ally.
Serotonin has frequently been implicated as
the agent responsible for these changes. Intra-
arterially (1) and intravenously (2) administered
serotonin has duplicated the flush response in
normal and carcinDid individuals; however,
Sehneckloth et al. (2) have reported norepineph-
rine and sodium nitroprusside to produce
typical flushes in carcinoid patients. Intracu-
taneously administered serotonin has not been
reported to produce these changes. Therefore, a
study to evaluate the cutaneous responses to
serotonin when administered intradermally and
the subsequent modification of these responses by
various agents was undertaken.
METHODS
Fifty healthy caucasian individuals were
studied; three-fourths were young males under
age 30; the remainder females and older males. No
consistent differences were noted between the
groups. Subjects were tested by intradermal injec-
tion of 0.1 cc. of various concentrations using dis-
posable plastic syringes. Test sites were the volar
forearm surfaces and the back. Solutions were ad-
justed to isotonicity with saline. Serotonin in the
form of 5-hydroxytryptamine creatinine sulfatet
and histamine phosphate were used with isotonic
saline for controls. Concentrations are expressed
in terms of the free base.
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As a measure of capillary permeability, six
volunteer subjects were given 25 mg. of Evans
Blue dye intravenously and thirty minutes later
their responses to intradermally injected materials
were measured.
Cutaneous microcirculation was examined by
capillary microscopy, using techniques previously
described (3). Serotonin was applied by dropping
it onto a site from which the keratin had been
removed by stripping with cellulose tape.
RESULTS
All the subjects tested responded to both
serotonin and histamine. Although specific re-
sponses to serotonin were variable, it regularly
produced local erythema, a prominent persistent
flare and constriction of large subcutaneous veins.
Cyanosis, pain and pruritus occurred incon-
sistently. There was virtually no wheal forma-
tion. The molar concentrations of serotonin re-
quired to produce these effects varied over a wide
range but were always greater than the concen-
trations of histamine required to produce com-
parable erythema or flare responses. In general,
the molar concentrations of serotonin required
were more than five times that of histamine. The
particular responses to serotonin will be dis-
cussed separately.
.Erytheina. Serotonin in a concentration of 5
micrograms per milliliter (y/ml) regularly pro-
duced easily visible local vasodilatation; 2 -y/ml
caused erythema in three-fourths of the subjects.
Concentrations as low as 0.1 /ml occasionally
produced erythema at the injection site. This
concentration approaches the concentration
available in human skin (4). Local erythema ap-
peared rapidly, becoming visible as soon as the
blanching produced by intradermal injection
had faded. The duration of erythema varied
from 15 to 180 minutes and was approximately
proportional to concentration.
The effects of various substances on serotonin-
induced local vasodilatation were studied in six
subjects. Following intradermal injection of the
test agent, the erythema resulting from a fixed
amount of serotonin and the threshold amount of
serotonin required to produce erythema were
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Complete Inhibition
Norepinephrine
Epinephrine
Neosynephrine
Isoproterenol
Ergotamine tartrate
Partial Inhibition
DCI (1-(3,4 Dichlorophenyl) 2 isopropyl-
amino ethanol HCL)
Cyproheptadine
5-hydroxytryptophane
BAS (1-benzyl-2-methyl-5-methoxy tryp-
tamine HCL) (500)
BOL-148 (2-bromo-d-lysergic acid dieth-
ylamide tartrate)
Numbers in parentheses refer to the smallest
effective concentrations, expressed as micrograms
per milliliter.
TABLE II
Numbers in parentheses refer to the greatest
concentrations tested, expressed as micrograms
per milliliter.
evaluated as contrasted to controls: two end
points were thus utilized. The agents which in-
hibited erythema are listed in Table un approxi-
mate order of potency. Complete inhibition was
obtained with a variety of vasoconstrictors; these
agents thus function as physiologic antagonists.
Pharmacologically induced vasoconstriction is
apparently a stronger cutaneous stimulus than
serotonin- or histamine-induced vasodilatation
for vasoconstrictors, e.g. norepincphrinc 2 y/ml,
not only prevented but also diminished or
blanched the erythema. White dermographism
(1) following gentle stroking did not affect the cry-
(1) thema but rather made it more visible by blanch-
(1) ing the surrounding skin.
(10) Partial inhibition was produced by a group of
(15) scrotonin antagonists of varying efficacy and also
by a blocker of beta adrcnergic receptors (DCI).
Differences between the compounds were small
(100) since these agents arc weak inhibitors at best. The
(200) end point of this response is not sharp and prc-
(200) cisc evaluation is difficult, necessitating a some-
what arbitrary point of division between the
weakest partial inhibitors and those with no
(500) effect. However, these agents did seem to exert
a partial albeit weak effect in the six subjects
tested.
Table II lists some agents which failed to affect
serotonin-indueed erythcma. In agreement with
the findings of Lorincz and Pearson (5), atropine,
antihistaminics and the monamine oxidase in-
hibitor iproniazid failed to influence local vaso-
dilatation.
Flare. Serotonin in a concentration of 20 7/mi
produced a flare response in all subjects; 10 y/ml
produced this response on the forearms in all but
two subjects, while on the back a flare was ob-
served with this concentration in approximately
three-fourths of the individuals tested. Some sub-
jects developed a discernible flare from concen-
trations as small as 1 y/ml.
The flare response appeared within 20 to 35
seconds after injection and attained its maximum
extent and intensity within five minutes. The
duration was in general porportional to the
amount of serotonin injected. The occasional
small faint flare produced by 1 y/ml lasted ap-
proximately 10 to 15 minutes, whereas the larger
more intense flares produced by higher concen-
trations occasionally lasted more than three
hours. In the majority of individuals, when com-
parable sized flares produced by histamine and
scrotoniu were contrasted, the scrotonin flare
was less intense, more mottled and very indis-
tinctly marginated. These variations are prob-
ably due to the degree of vasodilatation and pre-
sumably do not represent qualitative differences.
Many substances were tested for their ability
to modify the scrotonin flare. Local anesthetics
and antihistamines (listed in Table II) infiltrated
TABLE I
Effect of Various Agents on Serotonin-induced
Local ITasodilatation
Agents Not Affecting Serotonin-Induced Local
Vasodilatation
Reserpine
Chlorpromazine
Atropine
Dibenzyline
Phentolamine
Hexamethonium
Tetraethylammonium Chloride
Tripelennamine
Chloroprophenpyridamine
Diphenhydiamine
Hydrocortisone
Desoxycortieosterone
Hexylcaine
Lidoeaine
Procaine
Iproniazid
(150)
(500)
(50)
(100)
(500)
(500)
(10)
(25,000)
(2,000)
(1,000)
(10,000)
(500)
(10,000)
(10,000)
(10,000)
(500)
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into the skin in anesthetic concentrations in-
hibited the histamine and serotonin flares equally
well, in agreement with the observations of other
investigators (5, 6). In subanesthetic concentra-
tions, only the vasoconstrictors (shown in Table
I) were effective inhibitors. Norepinephrine
proved most potent. In the six subjects tested
none of the serotonin antagonists (Table I) and
none of the agents listed in Table II modified
the serotonin or histamine flares when anes-
thesia was not produced. These results suggest
that the serotonin flare is mediated by axon
reflex vasodilatation, probably of arterioles (al-
though differential surface temperature measure-
ments have not yet been performed). Conceivably
the differences between histamine and serotonin
flares may result from vasodilatation at differ-
ent arteriolar levels rather than varying degrees
of dilatation of the same vessels.
Cyanosis. In approximately one subject out of
four, larger concentrations of serotonin produced
cyanosis varying in degree from a barely de-
tectable halo surrounding the flare to a large
bluish-tinged area extending for several centi-
meters beyond the flare (Fig. 1). One subject
routinely developed cyanosis from a single in-
jection of 20 'y/ml; most of the susceptible in-
dividuals required from 100 to 300 y/ml. Cyano-
sis was discernible within two minutes, reached a
maximum in 5 to 10 minutes and usually per-
sisted from 20 to 90 minutes, occasionally lasting
3 hours; duration was approximately propor-
tional to concentration.
Cyanosis induced by lower concentrations of
serotonin (20 to 50 7/mI) tended to last longer
than the small flare produced, whereas with
higher concentrations the large, intense flare was
generally of longer duration than the cyanosis.
When several injections of serotonin were made
in proximity to each other the cyanosis develop-
ing between injection sites was more intense than
that surrounding the entire area. Cyanosis never
occurred in the absence of a flare response, how-
ever this probably only reflects the larger con-
centrations required to produce either response.
The forearms of subjects susceptible to cyanosis
gave a greater response than did the back. In
some individuals, as little as 50 to 100 micrograms
(0.1 ml of 0.5 to 1 mg/mi) of serotonin injected in
the volar forearm led to cyanosis extending from
the middle of the upper arm to the fingers. The
cyanosis was interspersed with erythematous areas
Fin. 1. The responses to intradermaliy injected
histamine and serotonin are contrasted. On the
left, histamine concentrations (from above down-
ward) range from 33 to 2 y/ml. An isotonic saline
control is included at the bottom left. Serotonin,
on the right, was injected in the following concen-
trations, 1000, 50, 500, 300 and 20 y/mI, readingdownward. Axon reflex flare (dark areas around
the injection papules) and cyanosis induced bylarger concentrations of serotonin (gray areas
extending several centimeters beyond the flare)
are visible. Photograph taken 6 minutes after
injection.
and as the response faded some blanching oc-
curred. Thus a mottled red, white and blue re-
sponse of the forearm was produced which, when
compared to the facial cutaneous flush exhibited
by two patients with functioning carcinoid tu-
mors, closely reproduced the characteristic carci-
noid appearance.
Those dilated venules of the subpapillary
plexus just visible with the naked eye, which
were included in a cyanotic area became prom-
inently congested with reduced blood, thereby
assuming a telangiectatic appearance which
persisted for a time after the cyanosis faded.
Intracutaneous application of the agents listed
in the prior tables did not prevent or reverse
cyanosis. These subjects also noted numbness,
paresthesias and coldness of the fingers as well as
pain. In a marked response the fingers became
several degrees cooler and the volume of the limb
(circumference measurement) increased. Plethys-
mographie studies are planned.
These responses can be attributed to erythema-
producing dilatation of the smaller arterioles or
metarterioles coupled with venoconstriction of
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Fia. 2. Capillaries and subpapillary plexuses of forearm prier to exposnre to serotonin (left). The
same area (right) 10 minutes after application of serotonin (200 '/m1). X34.
the larger veins producing cyanosis. As a model
for this hypothesis, cyanosis of an extremity was
induced with a blood pressure cuff set below
arterial pressure. In this situation small amounts
of histamine or serotonin were able to produce
erythema (though somewhat diminished) in a
cyanotic skin. The slower appearance of cyano-
sis is attributed to the time required for serotonin
to diffuse to larger veins. Diffusion losses may
explain the relatively high concentrations re-
quired despite the known sensitivity of larger
veins to scrotonin. The decreased temperature
and increased volume of the extremity can be
explained by diminished venous outflow.
Venocon.striction. Locally applied serotonin
produced constriction of large subcutaneous veins
causing their disappearance from view, as first
reported by Reid (7). Serotonin caused vcno-
constriction in all of the subjects tested. When
placed in proximity to a vein, concentrations
as small as 0.5 y/ml applied either intradermally
or by direct application to a stripped area
caused short-lived vein collapse in occasional
subjects. Most subjects developed venocon-
striction with concentrations less than 10 y/ml
(Fig. 2). This appeared within 1 to 3 minutes
and persisted as long as one hour. Two subjects
required 20 y/ml in order to induce the phe-
nomenon. Larger amounts of scrotonin resulted
in venoconstriction of two to three hours or
longer.
Many agents including the serotonin antag-
onists and the other drugs listed in the prior
tables did not influence this phenomenon; none
of these drugs caused venoconstriction and con-
versely their application prior to scrotonin failed
to inhibit venoconstriction. These findings arc
in agreement with those of Lorinox and Pearson
(5); these authors were also unable to modify
this phenomenon with several agents, including
local anesthetics, and felt venoconstriction to
be a direct action of scrotonin.
Pain. Pain following scrotonin injection was
an inconstant finding. Only two subjects spon-
taneously complained of prolonged deep pain
though several mentioned its presence on direct
questioning. Two individuals noted tenderness
of the scrotonin papulcs to pressure without
concomitant pain. Spontaneous and presumably
significant pain was elicited only with the higher
concentrations (500 'y/ml and above). The
severity of pain which a given amount of sero-
tonin produced was quite variable even in the
same subject. Pain seemed to be most intense in
subjects who developed prominent cyanosis
though pain did occur without detectable
cyanosis. When intense, pain was noted approxi-
matcly 3 minutes after injection and often per-
sisted more than 3 hours. Thus pain appeared
shortly after and somewhat outlasted cyanosis.
The deep pain may be attributed to constriction
of the large veins and consequent fluid accumu-
lation producing stretching of the tissues.
Pruritus. The majority of subjects experienced
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almost immediate pruritus following injection
of larger concentrations of serotonin (1 mg/ml
and above). These concentrations produced
whealing, often with the appearance of pseudo-
pods, presumably by causing histamine release.
Concentrations too small to induce evidence of
histamine release caused pruritus no more fre-
quently than did isotonic saline.
Wheal. In all but three subjects, serotonin in
concentrations as large as 200 -y/ml did oot pro-
duce detectable whealing. The serotonin injection
papules became no larger and persisted no
longer than saline controls. In three subjects this
concentration resulted in slightly larger wheals
than those produced by saline. A concentration
of 300 y/ml induced a wheal of approximately
25 per cent greater diameter than controls in
one-third of subjects. A serotonin wheal twice
the size of control papules was produced by a
concentration of 500 y/ml in the majority of
subjects. With concentrations of 1000 'y/ml and
greater, all subjects demonstrated grossly visible
wheals which frequently developed pseudopods.
Most of the patients noted pruritus with these
concentrations and it may be assumed that
serotonin had induced histamine release.
In order to facilitate study of serotonin's abil-
ity to produce whealing, volunteer subjects
were given Evans Blue dye intravenously. This
dye migrates with serum proteins and by stain-
ing edema fluid serves as a convenient indicator
of increased capillary permeability. Serotonin
was contrasted with agents known to affect the
permeability of human capillaries. These included
histamine and plasma permeability factor (8). In
concentrations up to 100 y/ml, serotonin failed
to produce any greater color of the injection
papules than did saline. In the range of 200 to
Fia. 3. Subcutaneous veins of forearm prior to serotonin (upper). Dark area is site from which keratin
has been stripped away. Serotonin (100 y/ml) was dropped onto this site. The same area (lower) 8 mm-
utes after serotonin shows constriction of the veins.
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500 y/ml, serotonin induced a faint bluing,
visible 15 minutes after injection. In order to
achieve bluing as rapid or as intense as produced
by 1 y/ml of histamine, concentrations of sero-
tonin approaching 1000 y/ml wcrc required.
One subject responded to 750 -y/ml while one
required 1500 'y/ml to achieve this degree of
bluing. Histamine release, as mentioned above,
is probably induced by these large concentra-
tions. The above results are substantially in
agreement with those obtained by Moller and
Rorsman (9) using sodium fluorescein as an
indicator of capillary transudation. These in-
vestigators found an antihistaminic compound
capable of reducing the exudation, wlule a sero-
tonin antagonist failed to do so, providing
further evidence that serotonin effects on human
capillary permeability are mediated by hist-
amine. Thns the ability of serotonin to directly
increase capillary permeability in human skin
appears to be negligible.
Microcirculation. The effects of serotonin on
cutaneous circulation were investigated with the
aid of capillary microscopy. Serotonin was
applied directly onto a site after removal of the
keratin. Concentrations of serotonin up to
200 'y/ml produced a slowing in the rate of blood
flow 10 to 15 minutes after application. There
were no morphologic changes of the capillaries
or subpapillary venules demonstrable (Fig. 3).
Larger concentrations in general caused no
greater response, though evidence of edema
formation (haziness and pallor of the back-
ground) was occasionally noted. These changes
are qualitatively similar to those observed with
other vasodilators including aeetyleholine and
histamine.
Examination of the mieroeireulation in an
area of serotonin-indueed cyanosis revealed the
rate of blood flow to be moderately slowed, and
the vessels to be engorged with reduced blood.
The microscopic changes were reproduced on
control limbs with a tourniquet set above
venous pressure, and these serotonin responses
can be attributed to constriction of larger veins.
DIScUSSION
One of the pronounced responses of human
skin to intraeutaneously administered serotonin
is constriction of large subcutaneous veins.
Despite the marked response by larger veins,
serotonin lacks a profound effect on smaller
vessels. There is no constriction of venules of the
subpapillary plexus demonstrable with capillary
microscopy.
The ability to produce direct venoeonstrietion
in man is a unique effect of serotonin and, to the
best of our knowledge, is a property shared by
no other available agent. This effect, first de-
scribed by Reid in 1952 (7), deserves further
evaluation for its significance as an important
physiological function of serotonin. Venoeon-
strietion, occurring in selected vascular areas, by
influencing blood flow and pressure on the
venous side of capillaries, may provide a mech-
anism for delicate cardiovascular control of ex-
change processes and metabolism.
Constriction of large subcutaneous veins
occurred in every subject tested and this re-
sponse is probably the basis of other observed
serotonia effects, particularly pain and cyanosis.
Pain has previously been reported following
administration of serotonin at the base of a
blister (10), where absorption may be enhanced.
Cyanosis in response to intradermal serotonin
has been reported by Rotbart (11) in two pa-
tients with malignant eareinoid tumors, however
we were unable to demonstrate this in three
patients, two of whom were experiencing typical
flushes when studied. Recently, Seherbel and
Harrison (12) have observed patients with
rheumatoid arthritis to develop cyanosis follow-
ing periartieular injection of serotonin.
Unlike venoeonstrietion, pain and cyanosis
could not be produced in a majority of subjects
studied. We do not presently understand the
factors other than venoeonstrietion controlling
cyanosis. Abnormality of serotonin metabolism
does not seem to be necessarily involved since
in our subjects exhibiting a marked cyanotic
response, determinations of plasma serotonin
and urinary 5-hydroxyindoleaeetie acid were
within normal limits.
Many pharmacologically active compounds
including the serotonin antagonists failed to
influence venoeonstrietion. Antiserotonin com-
pounds do not effectively antagonize any of the
responses of human skin to serotonin, nor do
these compounds inhibit the effects of serotonin
on the gastrointestinal tract. In this respect the
receptors of the gastro-intestinal tract and
human skin are similar.
The ability of serotonin to markedly increase
capillary permeability was first reported by
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Rawley and Benditt (13), who noted serotonin
to be more effective than histamine in its ability
to produce edema of the rat's paw. Sparrow and
Wilhelm (14) noted marked species differences
in this response; serotonin was very effective in
rats but in rabbits and guinea pigs its effect was
negligible. Human skin apparently responds
like that of rabbits and guinea pigs for no sig-
nificant increase in capillary permeability by
serotonin has been demonstrated. These results
make it dubious that serotonin plays any im-
portant direct role in whealing phenomena in
human skin, though the possibility of an indirect
adunctive action cannot be excluded and
remains to be studied. Some patients with the
carcinoid syndrome have been noted to have
facial and periorbital edema with severe flushing
(15). This edema may be the result of veno-
constriction or might be due to increased amounts
of circulating histamine rather than serotonin
since some of these patients are reported by
Pernow and Waldenstrom (16) to excrete large
amounts of histamine in the urine.
SUMI,IARY
Various responses to intradermally adminis-
tered serotonin were studied in fifty normal sub-
jects. All developed local erythema, a prominent
protracted flare and constriction of large sub-
cutaneous veins, although the small vessels
showed no marked changes. Cyanosis developed
in approximately one-fourth of the subjects
while pain was only occasionally noted. Pruritus
was insignificant except in association with
other evidence of histamine release. Serotonin
did not significantly increase capillary transuda-
tion of Evans Blue dye. Many agents were
examined for their ability to inhibit responses
to serotonin and while physiologic antagonisms
were observed, none of the serotonin antag-
onists was effective in modifying the cutaneous
responses. The role of venoconstriction as an
important physiological function of serotonin is
discussed.
REFERENCES
1. RODDIE, I. C., SHEPARD, J. T. AND WHELAN,
R. F.: The action of 5-Hydroxytryptamine
on the blood vessels of the human hand and
forearm. Brit. J. Pharmacol., 10: 445, 1955.
2. SCHNECKLOTH, R., PAGE, I. H., DEL GRECO, F.
AND CORCORAN, A. C.: Effects of serotonin.
antagonists in normal subjects and patients
with carcinoid tumors. Circulation, Off. J.
of the Amer. Heart Assoc., 16: 523—532, 1957.
3. DAVIs, M. J. AND LORINCZ, A. L.: An improved
technic for capillary microscopy of the skin.
J. Invest. Dermat., 28: 283—290, 1957.
4. WEST, G. B. AND PARRATT, J. R.: 5-Hydroxy-
tryptamine and the skin. Arch. Dermat. &
Syph., 76: 336—342, 1957.
5. LoiuNcz, A. L. AND PEARSON, R. W.: Studies
on axon reflex vasodilatation and cholinergic
urticaria. J. Invest. Dermat., 32: 429—435,
1959.
6. CLENDENNING, W. E., DEOREO, G. A. AND
STOUGLITON, R. B.: Serotonin; Its effect in
normal and atopic skin. Arch. Dermat. &
Syph., 79: 503—511, 1959.
7. REID, G.: Circulatory effects of 5-hydroxy-
tryptamine. J. Physiol., 118: 435, 1952.
8. WILHELM, D. L., MJLES, A. A. AND MACKAY,
MARGARET E.: Enzyme-like globulins from
serum reproducing the vascular phenomena
of inflammation. Brit. J. Exper. Path., 36:
82, 1955.
9. M0LLER, HALVOR AND RORSMAN, HANS:
Studies on vascular permeability factors
with sodium fluoreseein. III. The effect in
man of intracutaneously injected 5-hy-
droxytryptamine. Acta dermat.-venereol.,
39: 12—16, 1959.
10. ARMSTRONG, D., DRY, R. M. L., KEELE, C. A.
AND MARKHAM, J. W.: Observations onehem-
ical excitants of cutaneous pain in man. J.
Physiol., 120: 326—351, 1953.
11. ROTBART, M.: Malignant Carcinoid Tumor:
Altered Reactivity of the Skin to Serotonin
in 2 patients, California Med., 88: 112, 1958.
12. ScHERBEL, A. L. AND HARRISON, J. W.: Re-
sponse to serotonin and its antagonists in
patients with rheumatoid arthritis and
related diseases. Angiology, 10: 29—33, 1959.
13. ROWLEY, D. A. AND BENEDITT, E. P.: 5-hy-
droxytryptamine and histamine as media-
tors of the vascular injury produced by
agents which damage mast cells in rats, J.
Exper. Med., 103: 399, 1956.
14. SPARROW, E. M. AND WILHELM, D. L. : Species
differences in susceptibility to capillary
permeability factors: Histamine, 5-hydroxy-
tryptamine, and compound 48/80, J.
Physiol., 137: 51, 1957.
15. SJOERDSMA, A.: Carcinoid Syndrome, in A
Textbook of Medicine, edited by Cecil, R.
I. and Loeb, R. F., Philadelphia, W. B.
Saunders Co., Tenth Edition, 1959.
16. PERNOW, B. AND WALDENSTROM, J.: Determi-
nation of 5-hydroxytryptamine, 5-hydroxy-
indole acetic acid and histamine in thirty-
three cases of carcinoid tumor (argentaffino-
ma). Am. J. Med., 23: 16—25, 1957.
DISCUSSION
DR. F. KALZ, (Montreal, Canada): I enjoyed
this paper particularly, as one is always inter-
ested in hearing about subjects one has been
working on oneself. There is particularly one
point I should like to discuss, namely whether
serotonin changes capillary permeability or not.
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We have been doing similar bluing experiments
and came to different results, but I must em-
phasize that our technic was somewhat different.
We have given up Evan's Blue since this dye
has several unpleasant features, chiefly we had
difficulties finding volunteers who were prepared
to put up with the resulting greyish blue dis-
coloration of the skin which persists for about
two weeks. We have used instead Coomassie
blue, a protein stain which stains selectively
plasma proteins, particularly the albumin frac-
tion. It has a very short half life and does not
stain the normal skin at all; any local serum
extravasation however, shows a bright blue stain
which persist for a couple of hours. If I may
show two slides, with the permission of the
Chairman: This series of bright blue wheals
represents dilutions of serotonin, from 10 mcms/
Ml up. This blue control is the histamine releaser
polymixin, the saline control remains unstained.
Now it is the question whether the bluing, which
indicates an increase in capillary permeability
is due to a direct action of serotonin upon the
capillaries, or whether injection of serotonin
releases histamine. \Vc have tried to deplete an
area of skin completely of histamine by means
of repeated iontophoresis with the potent hist-
amine releaser 48/80; and then to inject the
test substance in this depleted area and a con-
trol area. Unfortunately, I have no data today
on the behavior of serotonin in this experiment
but will report the results later.
Da. RICHARD B. STOUGHTON, (Cleveland,
Ohio): Many have been interested in serotonin,
including ourselves. I think one interesting
point that is worth bringing up is the species
difference that exists with serotonin. Rowley
and Benditt (J. Exper. Med. 103: 399, 1956)
demonstrated that serotonin is a most effective
agent for increasing capillary permeability in
the rat. Workers today indicate from their
work that serotonin does not increase capillary
permeability. There have been other ancillary
observations that have differed from one set of
investigators to another and I wonder if perhaps
this could be due to contaminants of an impure
product and possibly due to differences in con-
centration that have been used.
DR. JOSEPH BENINSON (Detroit, Michigan):
Many of the remarks made here today bring to
mind some of the discussion which was held by
some of your colleagues at the International
Congress of Angiology.
Yesterday, Dr. Hadding of Northwestern
discussed serotonin in the vascular bed and
pointed out the same facts that Dr. Stoughton
just mentioned. He noted the very precise differ-
ences of action of serotonin between species.
Then, he emphasized that the effect could be
different depending upon the concentrations of
serotonin being used.
He described a series of experiments where
giving 10 gamma of serotonin intravenously did
not affect the arterioles and venules but did
affect the capillaries. Since serotonin acts on the
larger arteries and veins, it does not really
affect the total blood flow, the total resistance,
or the total blood volume that comes through a
specific area of tissue.
I trust that this may throw a little more light
on some of the observations that have been
made here today.
DR. D. JOSEPH DEans (in closing): I would
like to thank all the discussants for their com-
ments. In agreement with Dr. Beninson's remarks,
we have observed little change in the capillaries
with serotonin. The most pronounced cutaneous
effects were exerted on the larger veins. We have
not carefully studied arterial effects but have
not observed constriction of the superficial
arteries. However, there is variability in the
responsiveness of large blood vessels to sero-
tonin; the pulmonary vessels appear to be most
responsive. Also, to reiterate what Dr. Stoughton
mentioned, there is, in addition, marked species
difference in responsiveness to serotonin. For
example, the capillaries of rat's paw seem to be
more sensitive to serotonin than are those of
other species.
In reply to Dr. Kalz, our technies are different.
With the quantity of Evans Blue we have em-
ployed, while the plasma retains a bluish tinge
for several weeks, none of our subjects has been
significantly discolored. It is difficult to under-
stand why the use of another indicator dye
should lead to such different results. The slide
presented showed deeply stained wheals with
concentrations of serotonin ranging upward
from 10 'y/ml. The wheals all appeared to be of
approximately equal intensity. Conceivably this
dye might in some way induce histamine release
by smaller amounts of serotonin or exert some
other adjunetivant effect. We hope the explana-
tion for these different results will become appar-
ent with further investigation.
